Reviva Pharmaceuticals Holdings Inc (RVPH): 23.9 improvement. No safety issues...

Send PM Follow Ignore

Re: McMagyar post# 43

Tuesday, 10/31/2023 6:25:59 PM

Tuesday, October 31, 2023 6:25:59 PM

23.9 improvement.

No safety issues

Get the sick the drug

The fda process sucks

Keep Last Read

Next 10 Prev Next

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:32:46 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:15 AM
Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/13/2024 10:00:49 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/02/2024 09:38:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:05:15 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/17/2023 09:03:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:12:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 12:20:19 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/04/2023 09:03:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 09:02:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/17/2023 10:30:33 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:16:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:15:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:16:19 PM

InvestorsHub NewsWire

FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM

FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM

Only $200 per official company press release!